AI Terminal
OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC
Declaration of Voting Results & Voting Rights Announcements • May 28, 2021
5066_rns_2021-05-28_1dfa0bc9-10b3-4aaf-a88a-4418b08df4bc.html
Declaration of Voting Results & Voting Rights Announcements
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 8646Z
Oxford Cannabinoid Tech.Holdings
28 May 2021
Oxford Cannabinoid Technologies Holdings Plc
Total Voting Rights
Oxford Cannabinoid Technologies Holdings Plc ("Company"), announces that, in accordance with FCA's Disclosure Guidance and Transparency Rules, as at 28 May 2021, the Company's issued share capital consists of 960,415,644 Ordinary Shares of £0.01, each with one voting right. The Company does not hold any Ordinary Shares in treasury. Therefore, the total number of voting rights in the Company is 960,415,644.
The above figure of 960,415,644 should be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.
For more information:
| The Company | ||
| Oxford Cannabinoid Technologies Holdings Plc | Dr John Lucas | +44 (0)7956 873125 |
| The Financial Adviser | ||
| Cairn Financial Advisers LLP | Emily Staples or Jo Turner | +44 (0)20 7213 0897 or +44 (0)20 7213 0885 |
| The Corporate Adviser | ||
| States Bridge Capital Ltd | Damion Carruel | +44 (0)7775516745 |
| The PR Adviser | ||
| Acuitas Communications | Simon Nayyar or James Gittings | 44 (0)20 3848 2815 or +44 (0)20 3848 2812 |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
TVRPPUACAUPGUMQ